News

ICYMI: Dr. Clark breaks down the results of the PANORAMA Study

ICYMI: Dr. Singh shares the take-home message from his 2019 presentation

ICMYI: Dr. Wykoff discusses results from his ASRS presentation

ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process

Despite cost, advantages include sensitivity, improved outcomes